Leading scientists now say a new flu pandemic is not so likely. But it pays to develop a vaccine stockpile -- the Feds are granting big bucks and biotech stock prices are soaring -- even though the SARS vaccine they rushed through will sit on the shelf.
Link To Original Article
Bird Flu Hype Infects Biotech
Linear Mode
